{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T10:34:09Z","timestamp":1785234849925,"version":"3.55.0"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:sec>\n            <jats:title>Background.<\/jats:title>\n            <jats:p>We investigated the effect of clinical and subclinical T cell\u2013mediated rejection (C-TCMR and SC-TCMR) on allograft histology, function, and progression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods.<\/jats:title>\n            <jats:p>Adult kidney recipients with 2 protocol biopsies were divided into No-TCMR on biopsies (n = 104), SC-TCMR (n = 56), and C-TCMR (n = 32) in at least 1 biopsy. Chronicity (ci + ct + cg + cv) scores, renal function, and the burden of renal disease measured by area under the curve (serum creatinine, mg mo\/dL) were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results.<\/jats:title>\n            <jats:p>Baseline characteristics were similar except for mean donor age and Kidney Donor Profile index scores. Patients with C-TCMR had higher mean serum creatinine, lower mean estimated glomerular filtration rate, and higher area under the curve with 95% confidence interval (75.2 [67.7-82.7]) as opposed to patients with SC-TCMR and No-TCMR (58.3 [53.6-62.9], 65.1 [58.8-71.5]), <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0004. Chronicity scores were higher at 3 months in C-TCMR (2.30 \u00b1 1.58) compared with SC-TCMR (2.02 \u00b1 1.42) and No-TCMR (1.31 \u00b1 1.18), <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.0001 and also at 12 months. At last follow-up, 18.8% patients with C-TCMR had \u226550% decline in estimated glomerular filtration rate from 3 months compared with 7% and 1% among No-TCMR and SC-TCMR groups (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.038). Multivariate analyses revealed higher odds of \u0394-creatinine \u2265 0.5\u2009mg\/dL from 3 months to last follow-up for C-TCMR (3.39 [95% confidence interval, 1.25-9.20]) versus No-TCMR (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.016).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions.<\/jats:title>\n            <jats:p>Kidney transplant recipients with C-\/SC-TCMR have heightened early allograft chronicity and worse renal function compared with those with No-TCMR. Progressive renal dysfunction was noted among patients with C-TCMR as opposed to SC-TCMR and No-TCMR.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/tp.0000000000002560","type":"journal-article","created":{"date-parts":[[2019,2,12]],"date-time":"2019-02-12T21:12:34Z","timestamp":1550005954000},"page":"1457-1467","source":"Crossref","is-referenced-by-count":41,"title":["The Impact of Early Clinical and Subclinical T Cell\u2013mediated Rejection After Kidney Transplantation"],"prefix":"10.1097","volume":"103","author":[{"given":"William","family":"Hoffman","sequence":"first","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajil","family":"Mehta","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana R.","family":"Jorgensen","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puneet","family":"Sood","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parmjeet","family":"Randhawa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine M.","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetan","family":"Puttarajappa","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirav A.","family":"Shah","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit D.","family":"Tevar","sequence":"additional","affiliation":[{"name":"Department of Surgery, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Hariharan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Thomas E Starzl Transplantation Institute, University of Pittsburgh Medical Center, Pittsburgh, PA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20231002","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1681\/ASN.V9112135","article-title":"Impact of renal cadaveric transplantation on survival in end-stage renal failure: evidence for reduced mortality risk compared with hemodialysis during long-term follow-up.","volume":"9","author":"Schnuelle","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R2-20231002","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant.","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-20231002","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ki.1996.307","article-title":"A study of the quality of life and cost-utility of renal transplantation.","volume":"50","author":"Laupacis","year":"1996","journal-title":"Kidney Int"},{"key":"R4-20231002","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1600-6143.2010.03283.x","article-title":"Long-term renal allograft survival in the United States: a critical reappraisal.","volume":"11","author":"Lamb","year":"2011","journal-title":"Am J Transplant"},{"key":"R5-20231002","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.14124","article-title":"OPTN\/SRTR 2015 Annual Data Report: Kidney.","volume":"17","author":"Hart","year":"2017","journal-title":"Am J Transplant"},{"key":"R6-20231002","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1111\/ajt.12370","article-title":"Kidney allograft survival after acute rejection, the value of follow-up biopsies.","volume":"13","author":"El Ters","year":"2013","journal-title":"Am J Transplant"},{"key":"R7-20231002","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJM200003023420901","article-title":"Improved graft survival after renal transplantation in the United States, 1988 to 1996.","volume":"342","author":"Hariharan","year":"2000","journal-title":"N Engl J Med"},{"key":"R8-20231002","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1681\/ASN.2014040399","article-title":"Subclinical rejection phenotypes at 1 year post-transplant and outcome of kidney allografts.","volume":"26","author":"Loupy","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R9-20231002","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1681\/ASN.V12suppl_1s48","article-title":"Steroid-resistant kidney transplant rejection: diagnosis and treatment.","volume":"12","author":"Bock","year":"2001","journal-title":"J Am Soc Nephrol"},{"key":"R10-20231002","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/j.1600-6143.2005.01230.x","article-title":"Subclinical rejection associated with chronic allograft nephropathy in protocol biopsies as a risk factor for late graft loss.","volume":"6","author":"Moreso","year":"2006","journal-title":"Am J Transplant"},{"key":"R11-20231002","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1111\/ajt.14933","article-title":"Subclinical inflammation phenotypes and long-term outcomes after pediatric kidney transplantation.","volume":"18","author":"Seifert","year":"2018","journal-title":"Am J Transplant"},{"key":"R12-20231002","doi-asserted-by":"crossref","first-page":"e12945","DOI":"10.1111\/ctr.12945","article-title":"Kidney allograft surveillance biopsy practices across US transplant centers: a UNOS survey.","volume":"31","author":"Mehta","year":"2017","journal-title":"Clin Transplant"},{"key":"R13-20231002","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1111\/j.1600-6143.2008.02159.x","article-title":"Banff 07 classification of renal allograft pathology: updates and future directions.","volume":"8","author":"Solez","year":"2008","journal-title":"Am J Transplant"},{"key":"R14-20231002","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/ajt.12590","article-title":"Banff 2013 meeting report: inclusion of c4d-negative antibody-mediated rejection and antibody associated arterial lesions.","volume":"14","author":"Haas","year":"2014","journal-title":"Am J Transplant"},{"key":"R15-20231002","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1111\/ajt.14627","article-title":"Short-term adverse effects of early subclinical allograft inflammation in kidney transplant recipients with a rapid steroid withdrawal protocol.","volume":"18","author":"Mehta","year":"2018","journal-title":"Am J Transplant"},{"key":"R16-20231002","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1053\/ajkd.1998.v31.pm9631863","article-title":"Proposed consensus for definitions and endpoints for clinical trials of acute kidney transplant rejection.","volume":"31","author":"Guttmann","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"R17-20231002","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1034\/j.1600-6143.2003.00176.x","article-title":"Evolution of endpoints for renal transplant outcome.","volume":"3","author":"Hariharan","year":"2003","journal-title":"Am J Transplant"},{"key":"R18-20231002","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/ajt.14099","article-title":"Big data, predictive analytics, and quality improvement in kidney transplantation: a proof of concept.","volume":"17","author":"Srinivas","year":"2017","journal-title":"Am J Transplant"},{"key":"R19-20231002","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1523-1755.2002.00424.x","article-title":"Post-transplant renal function in the first year predicts long-term kidney transplant survival.","volume":"62","author":"Hariharan","year":"2002","journal-title":"Kidney Int"},{"key":"R20-20231002","doi-asserted-by":"crossref","first-page":"S401","DOI":"10.1097\/01.tp.0000543174.55576.5f","article-title":"Thymoglobulin induction decreases risk of ABMR and death in kidney recipients.","volume":"102","author":"Loheac","year":"2018","journal-title":"Transplantation"},{"key":"R21-20231002","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1681\/ASN.V9112129","article-title":"Beneficial effects of treatment of early subclinical rejection: a randomized study.","volume":"9","author":"Rush","year":"1998","journal-title":"J Am Soc Nephrol"},{"key":"R22-20231002","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1097\/01.TP.0000128167.60172.CC","article-title":"Natural history, risk factors, and impact of subclinical rejection in kidney transplantation.","volume":"78","author":"Nankivell","year":"2004","journal-title":"Transplantation"},{"key":"R23-20231002","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1600-6143.2012.04013.x","article-title":"Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant.","volume":"12","author":"Wiebe","year":"2012","journal-title":"Am J Transplant"},{"key":"R24-20231002","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/ajt.14565","article-title":"T cell\u2013mediated rejection is a major determinant of inflammation in scarred areas in kidney allografts.","volume":"18","author":"Lefaucheur","year":"2018","journal-title":"Am J Transplant"}],"container-title":["Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00028","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T05:28:13Z","timestamp":1696224493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007890-201907000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":24,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/tp.0000000000002560","relation":{},"ISSN":["0041-1337"],"issn-type":[{"value":"0041-1337","type":"print"}],"subject":[],"published":{"date-parts":[[2019,7]]}}}